T 2411/18 (BUFFER SOLUTIONS HAVING SELECTIVE BACTERICIDAL ACTIVITY AGAINST GRAM NEGATIVE BACTERIA AND METHODS OF USING SAME/United Therapeutics Corporation) of 14.10.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T241118.20211014
- Date of decision
- 14 October 2021
- Case number
- T 2411/18
- Petition for review of
- -
- Application number
- 08829225.5
- IPC class
- A61K 47/18A61K 31/5575
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- BUFFER SOLUTIONS HAVING SELECTIVE BACTERICIDAL ACTIVITY AGAINST GRAM NEGATIVE BACTERIA AND METHODS OF USING SAME
- Applicant name
- United Therapeutics Corporation
- Opponent name
- Teva Pharmaceutical Industries Ltd
Generics (U.K.) Limited - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 53(c)European Patent Convention Art 54(5)European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Admission of a new document (Yes)
Main request - Extension beyond the content of the application as filed (Yes)
Auxiliary request 1 - Extension beyond the content of the application as filed (No)
Auxiliary request 1 - Inventive step (No)
Choice of the closest prior art
Problem Invention (No)
Auxiliary request 2 - Extension beyond the content of the application as filed (Yes)
Auxiliary request 3 - Article 53(c) EPC - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked